Search: WFRF:(Miletic Hrvoje)
> (2007-2009) >
Anti-VEGF therapies...
Anti-VEGF therapies for malignant glioma : treatment effects and escape mechanisms
-
Miletic, Hrvoje (author)
-
Niclou, Simone P (author)
-
- Johansson, Mikael (author)
- Umeå universitet,Onkologi,NorLux Neuro-Oncology Laboratory, CRP-Santé, Luxembourg
-
show more...
-
Bjerkvig, Rolf (author)
-
show less...
-
(creator_code:org_t)
- 2009-03-31
- 2009
- English.
-
In: Expert opinion on therapeutic targets. - : Taylor & Francis. - 1472-8222 .- 1744-7631. ; 13:4, s. 455-468
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Background: Glioblastoma multiforme (GBM) has a very poor prognosis and novel treatment strategies are urgently needed. GBM appears to be an optimal target for anti-angiogenic therapy as the tumour shows a high degree of endothelial cell proliferation and pro-angiogenic growth factor expression. Objective: To examine the role of angiogenic factors (particularly VEGF) in glioma and whether inhibition of these factors can be used as a treatment.Methods: A review of relevant literature.Results/conclusions: Anti-angiogenic therapy has fulfilled the proof of concept in glioma animal models. In glioma patients, the efficacy of anti-angiogenic mono-therapies initially has been disappointing. However recent clinical trials combining bevacizumab, an anti-VEGF antibody, with chemotherapy reported very encouraging response rates. Although randomized phase III clinical trials with anti-angiogenic molecules are not yet available for GBM patients, this treatment regimen is already applied off protocol in several clinical centers. It should be kept in mind though that tumours can develop escape mechanisms. In particular invasive cells, which migrate away from the highly vascularized tumour core, are not targeted by anti-angiogenic therapies. In our opinion, the future of anti-angiogenic therapy will rely on a combination strategy including chemotherapy and drugs that target invasive glioma cells.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Samhällsfarmaci och klinisk farmaci (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Social and Clinical Pharmacy (hsv//eng)
Keyword
- angiogenesis
- cancer stem cells
- glioblastoma
- invasion
- therapy
- VEGF
Publication and Content Type
- ref (subject category)
- for (subject category)
Find in a library
To the university's database